Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03513952
Title Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

urethra transitional cell carcinoma


Atezolizumab + CYT107


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Kaiser Permanente-Riverside Suspended Riverside California 92505 United States Details
Moffitt Cancer Center Recruiting Tampa Florida 33612 United States Details
Straub Clinic and Hospital Suspended Honolulu Hawaii 96813 United States Details
University of Hawaii Cancer Center Suspended Honolulu Hawaii 96813 United States Details
University of Chicago Comprehensive Cancer Center Recruiting Chicago Illinois 60637 United States Details
East Jefferson General Hospital Recruiting Metairie Louisiana 70006 United States Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
FHCC South Lake Union Recruiting Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field